亚太地区神经康复设备市场预测至 2031 年 - 区域分析 - 按产品类型(神经机器人系统、脑机接口、非侵入性刺激器和可穿戴设备)、应用(中风、创伤性脑损伤、脊髓损伤、帕金森病、脑瘫等)和最终用户(康复中心、医院和诊所以及家庭护理)

Historic Data: 2021-2022   |   Base Year:    |   Forecast Period: 2024-2031


No. of Pages: 125    |    Report Code: BMIRE00031350    |    Category: Life Sciences

Asia Pacific Neurorehabilitation Devices Market
2023 年,亚太地区神经康复设备市场价值为 4.454 亿美元,预计到 2031 年将达到 13.9971 亿美元;预计 2023 年至 2031 年的复合年增长率为 15.4%。

市场参与者的战略举措推动亚太地区神经康复设备市场发展

市场参与者采取的战略举措,例如合并、收购、建立合作伙伴关系和协作,可能会加速创新、发展专业知识并扩大市场范围。

2022 年 4 月,Blackrock Neurotech 与神经科技初创公司 Phantom Neuro 合作,对 Phantom Neuro 正在申请专利的 Phantom X 系统进行研发,该系统为患者提供对当前和下一代辅助设备(如假肢和外骨骼)的高度准确、几乎实时的控制。此次研发合作使 Phantom 能够利用 Blackrock 在神经技术领域数十年的经验,开发生物相容性的植入式传感器,以补充和支持 Phantom X 平台。

2022 年 12 月,医疗用外骨骼技术领导者 Ekso Bionics 宣布收购 Parker Hannifin Corporation 的人体运动与控制(“HMC”)业务部门。此次收购将增强 Ekso 的产品组合,并改善其与范德比尔特大学等商业和研究伙伴的战略关系。与范德比尔特的合作有望增强其研究能力和产品开发。

因此,市场参与者采取的战略举措很可能在不久的将来为神经康复市场创造丰厚的机会。

亚太神经康复设备市场概览

神经系统疾病发病率的增加加上人口老龄化推动了对有效康复解决方案的需求。帕金森病 (PD) 是中国常见的神经退行性疾病。据《中国日报》报道,截至 2023 年 2 月,中国约有 400 万 PD 患者,65 岁以上人群中约有 1.7% 被诊断出患有该病。神经康复设备对于控制帕金森病的症状至关重要,帕金森病的特点是运动和非运动障碍,严重影响患者的生活质量。这些设备有助于增强运动功能、改善步态和平衡,并促进患者的日常活动。

预计在预测期内,机器人技术的进步和公司的战略努力将为中国市场带来潜在的增长机会。

亚太神经康复设备市场收入和预测到 2031 年(百万美元)

亚太神经康复设备市场细分

亚太神经康复设备市场分为产品类型、应用、最终用户和国家/地区。

按产品类型划分,亚太神经康复设备市场分为神经机器人系统、脑机接口、非侵入性刺激器和可穿戴设备。脑机接口部分在 2023 年占据亚太神经康复设备市场份额的最大份额。

在应用方面,亚太神经康复设备市场分为中风、创伤性脑损伤、脊髓损伤、帕金森病、脑瘫等。中风部分在 2023 年占据亚太神经康复设备市场份额的最大份额。

按最终用户划分,亚太神经康复设备市场分为康复中心、医院和诊所以及家庭护理。 2023 年,医院和诊所部门占据了亚太地区神经康复设备市场的最大份额。

根据国家/地区,亚太地区神经康复设备市场细分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。2023 年,中国部门占据了亚太地区神经康复设备市场的最大份额。

雅培实验室;BIONIK;BioXtreme Ltd;Blackrock Microsystems Inc;Ekso Bionics Holdings Inc;EMOTIV;Hocoma AG;Medtronic Plc;Renishaw Plc;和 Tyromotion GmbH 是亚太地区神经康复设备市场的一些领先公司。

Asia Pacific Neurorehabilitation Devices Strategic Insights

Strategic insights for Asia Pacific Neurorehabilitation Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-neurorehabilitation-devices-market-strategic-framework.webp
Get more information on this report

Asia Pacific Neurorehabilitation Devices Report Scope

Report Attribute Details
Market size in 2023 年为 4.454 亿美元
Market Size by 到 2031 年将达到 13.9971 亿美元
Global CAGR ()
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品类型
  • 神经机器人系统
  • 脑机接口
  • 非侵入性刺激器
  • 可穿戴设备
By 应用
  • 中风
  • 创伤性脑损伤
  • 脊髓损伤
  • 帕金森病
  • 脑瘫
By 最终用户
  • 康复中心
  • 医院和诊所
  • 家庭护理
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • BIONIK
  • BioXtreme Ltd
  • Blackrock Microsystems Inc
  • Ekso Bionics Holdings Inc
  • EMOTIV
  • Hocoma AG
  • Medtronic Plc
  • Renishaw Plc
  • Tyromotion GmbH
  • Get more information on this report

    Asia Pacific Neurorehabilitation Devices Regional Insights

    The regional scope of Asia Pacific Neurorehabilitation Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-neurorehabilitation-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Neurorehabilitation Devices Market

    1. Abbott Laboratories
    2. BIONIK
    3. BioXtreme Ltd
    4. Blackrock Microsystems Inc
    5. Ekso Bionics Holdings Inc
    6. EMOTIV
    7. Hocoma AG
    8. Medtronic Plc
    9. Renishaw Plc
    10. Tyromotion GmbH
    Frequently Asked Questions
    How big is the Asia Pacific Neurorehabilitation Devices Market?

    The Asia Pacific Neurorehabilitation Devices Market is valued at 2023 年为 4.454 亿美元 in , it is projected to reach 到 2031 年将达到 13.9971 亿美元 by .

    What is the CAGR for Asia Pacific Neurorehabilitation Devices Market by ()?

    As per our report Asia Pacific Neurorehabilitation Devices Market, the market size is valued at 2023 年为 4.454 亿美元 in , projecting it to reach 到 2031 年将达到 13.9971 亿美元 by . This translates to a CAGR of approximately during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Neurorehabilitation Devices Market report typically cover these key segments-

  • 产品类型 (神经机器人系统, 脑机接口, 非侵入性刺激器, 可穿戴设备)
  • 应用 (中风, 创伤性脑损伤, 脊髓损伤, 帕金森病, 脑瘫)
  • 最终用户 (康复中心, 医院和诊所, 家庭护理)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Neurorehabilitation Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Neurorehabilitation Devices Market report:

  • Historic Period : 2021-2022
  • Base Year :
  • Forecast Period : 2024-2031
  • Who are the major players in Asia Pacific Neurorehabilitation Devices Market?

    The Asia Pacific Neurorehabilitation Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • BIONIK
  • BioXtreme Ltd
  • Blackrock Microsystems Inc
  • Ekso Bionics Holdings Inc
  • EMOTIV
  • Hocoma AG
  • Medtronic Plc
  • Renishaw Plc
  • Tyromotion GmbH
  • Who should buy this report?

    The Asia Pacific Neurorehabilitation Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Neurorehabilitation Devices Market value chain can benefit from the information contained in a comprehensive market report.